We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Genmab AS | TG:GE9 | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -2.80 | -1.37% | 201.30 | 200.30 | 202.20 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 204.10 | 200.00 | 204.10 | 1,099 | 22:50:06 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 23/1/2025 | 20:08 | UKREG | Grant of Restricted Stock Units and Warrants to Employees in Genmab |
| 22/1/2025 | 11:23 | UKREG | Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024 |
| 03/1/2025 | 18:55 | UKREG | Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
| 11/12/2024 | 13:20 | UKREG | Genmab to Hold 2024 R&D Update and ASH Data Review Meeting |
| 09/12/2024 | 17:00 | UKREG | Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20).. |
| 08/12/2024 | 16:00 | UKREG | Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High.. |
| 08/12/2024 | 00:12 | UKREG | Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy.. |
| 03/12/2024 | 21:35 | UKREG | Capital Increase in Genmab as a Result of Employee Warrant Exercise |
| 03/12/2024 | 12:07 | UKREG | Transactions With Shares and Linked Securities in Genmab A/S Made by.. |
| 25/11/2024 | 16:05 | UKREG | Genmab to Present at Citi’s Global Healthcare Conference |
1 Year Genmab AS Chart |
Intraday Genmab AS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
